Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT04507178

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04507178
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04507178. Randomized; single masking; primary purpose prevention. Start 2022-02-02 (actual); primary completion 2026-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
Acronym
ISCHEMIA
Condition
Aneurysmal Subarachnoid Hemorrhage
Condition
Delayed Cerebral Ischemia
Intervention (Drug)
Nadroparin Injectable Product
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (class: other)

Record details

Record id
cardio:ct-nct04507178
Content hash
a7356c2e6d9089f3a7ca9c779926d39c2218e48893df454da316885451f6eec6